Vaxart Inc (NASDAQ:VXRT) shares, rose in value, with the stock price down by -2.50% to the previous day’s close as strong demand from buyers drove the stock to $0.77. Actively observing the price movement in the last trading, the stock closed the session at $0.78,
Vaxart, Inc. (Nasdaq: VXRT), a clinical-stage biotechnology company specializing in the discovery, development, and commercialization of oral recombinant vaccines, announced that its founder and chief scientific officer, Sean Tucker, will be giving a presentation at the upcoming World Vaccine Congress Washington on May 4-6, 2021.
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
